Literature DB >> 1582323

Rapid evolution of cardiac tamponade due to bacterial pericarditis in two patients with HIV-1 infection.

M M Karve1, M R Murali, H M Shah, K R Phelps.   

Abstract

We describe two HIV-seropositive patients with acute pneumococcal empyema and pericarditis. Cardiac tamponade evolved rapidly in each patient and was reversed with prompt surgical intervention. In each case, immunologic abnormalities were detected which could have facilitated local spread of infection and progression to tamponade. Pericarditis, an otherwise rare manifestation of pneumococcal infection in the antibiotic era, should be anticipated in HIV-seropositive patients with pneumococcal empyema.

Entities:  

Mesh:

Year:  1992        PMID: 1582323     DOI: 10.1378/chest.101.5.1461

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Pyopericardium followed by constrictive pericarditis due to Corynebacterium diphtheriae.

Authors:  Athanassios Krassas; Timothy Sakellaridis; Michalis Argyriou; Christos Charitos
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-03-08

2.  A case of cardiac tamponade due to an isolated abscess in the ascending aorta of a pregnant woman with a history of intravenous substance abuse.

Authors:  Brandy Shattuck; John Livingstone
Journal:  Forensic Sci Med Pathol       Date:  2017-03-17       Impact factor: 2.007

3.  Purulent pericarditis due to co-infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in a patient with features of advanced HIV infection.

Authors:  Andrew Louw; Mohammed Tikly
Journal:  BMC Infect Dis       Date:  2007-03-08       Impact factor: 3.090

4.  Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection.

Authors:  Daniel B Chastain; Travis S King; Kayla R Stover
Journal:  Open AIDS J       Date:  2016-06-06

5.  Echocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria.

Authors:  D A Olusegun-Joseph; J N A Ajuluchukwu; C C Okany; A C Mbakwem; D A Oke; N U Okubadejo
Journal:  Cardiovasc J Afr       Date:  2012-07-30       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.